Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Latest Attention Deficit Hyperactivity Disorder (ADHD) News and Research

New insight into 22q11.2 deletion syndrome

Research out of the George Washington University (GW), published in the journal Proceedings of the National Academy of Sciences (PNAS), reveals another piece of the puzzle in a genetic developmental disorder that causes behavioral diseases such as autism.

4 Jan 2013

Misdiagnosis of obsessive compulsive disorder and ADHD can jeopardize patient care

On the surface, obsessive compulsive disorder (OCD) and attention deficit/hyperactivity disorder (ADHD) appear very similar, with impaired attention, memory, or behavioral control. But Prof. Reuven Dar of Tel Aviv University's School of Psychological Sciences argues that these two neuropsychological disorders have very different roots - and there are enormous consequences if they are mistaken for each other.

20 Dec 2012

New way to effectively make designer drugs that hit collections of protein targets simultaneously

An international research collaboration led by scientists at the University of North Carolina School of Medicine and the University of Dundee, in the U.K., have developed a way to efficiently and effectively make designer drugs that hit multiple protein targets at once.

13 Dec 2012

ADHD comorbidity confounds brain findings in bipolar disorder

Structural brain abnormalities found in patients with bipolar disorder may have been wrongly attributed to the condition and in fact be associated with comorbid attention–deficit hyperactivity disorder, US researchers believe.

7 Dec 2012

Mental health amongst top reasons why young people attend GPs in Mid West Ireland

A recent study of primary care support for youth mental health in the Mid West was undertaken by researchers at the Centre for Interventions in Infection, Inflammation & Immunity (4i), Graduate Entry Medical School, UL (www.4i.ie). The researchers surveyed physicians in Limerick, Clare, and North Tipperary and found mental health and family conflict represented the most frequent reasons why young people attended GPs.

29 Nov 2012

Pfizer completes acquisition of NextWave Pharmaceuticals

Pfizer Inc. today announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc., a privately held, specialty pharmaceutical company focused on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD).

29 Nov 2012

Allergies common in ADHD, tic disorder patients

A significant number of people with attention deficit/hyperactivity disorder and tic disorder also have one or more allergic diseases such as asthma or atopic dermatitis, show study results.

23 Nov 2012

Chromosome 22q11.2 deletion syndrome anxiety linked to poorer adaptive behaviors

UC Davis researchers have found that for children with the genetic disorder known as chromosome 22q11.2 deletion syndrome anxiety -- but not intelligence -- is linked to poorer adaptive behaviors, such as self-care and communication skills, that affect daily life. The developmental syndrome, which is associated with a constellation of physical, cognitive and psychiatric problems, usually is apparent at birth or early childhood, and leads to lifelong challenges.

6 Nov 2012

John Wiley & Sons launches Molecular Genetics & Genomic Medicine

John Wiley & Sons, Inc., today announced the launch of Molecular Genetics & Genomic Medicine (MGGM), a new Wiley Open Access journal. Under the leadership of Editor-in-Chief Dr. Maximilian Muenke, the journal will provide rapid dissemination of high-quality research in all areas of human, medical and molecular genetics.

6 Nov 2012

Aerobic exercise may offer new treatment option for ADHD

Research suggests that moderate aerobic exercise may offer a new treatment option for children with attention deficit/hyperactivity disorder.

1 Nov 2012

ADHD linked to altered neural activation in bipolar patients

Bipolar disorder patients with and without comorbid attention-deficit hyperactivity disorder differ in neural activation patterns during response inhibition, results from a US study show.

26 Oct 2012

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012

Kids with ADHD tend to feel that they benefit from medications

Children living with attention deficit hyperactivity disorder (ADHD) tend to feel that they benefit from medication to treat the condition and do not feel that the medication turns them into 'robots', according to a report published today. In fact, they report feeling that medication helps them to control their behaviour and make better decisions.

19 Oct 2012

VOICES of children with ADHD support medication use

Children with attention deficit/hyperactivity disorder benefit from the use of stimulant medication and do not feel that it turns them into “robots,” suggests research.

16 Oct 2012

Men with childhood ADHD have multiple disadvantages throughout their lifetime

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.

16 Oct 2012

Contaminated fish pose dietary dilemma for pregnant women

Exposure to low levels of mercury in utero increases a child’s risk for developing attention deficit/hyperactivity disorder, report researchers.

10 Oct 2012

BDNF deletion plays a critical role in psychiatric disease and obesity

McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity. The key lies in the genomic deletion of brain-derived neurotrophic factor, or BDNF, a nervous system growth factor that plays a critical role in brain development.

9 Oct 2012

Prenatal fish consumption may reduce risk of ADHD-related behaviors

A study of children in the New Bedford, Mass., area suggests that low-level prenatal mercury exposure may be associated with a greater risk of attention-deficit/hyperactivity disorder (ADHD)-related behaviors and that fish consumption during pregnancy may be associated with a lower risk of these behaviors, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.

9 Oct 2012

Differentiating features of BD, early-onset ADHD identified

Research findings published in the Journal of Abnormal Child Psychology have identified differentiating features between early-onset bipolar disorder and combined attention-deficit/hyperactivity disorder.

3 Oct 2012

Noven initiates d-Amphetamine Transdermal System Phase 2 study in ADHD

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.

3 Oct 2012